GLP-1 receptor agonists in type 2 diabetes clinical audit
This clinical audit reviews GPs' use of the GLP-1 receptor agonist class of T2D medications in line with the latest Australian and international guidelines, supporting effective glycaemic management and improving patients' overall outcomes and quality of life.
Sign up for free and continue reading
Med CPD offers the widest range of courses and content, all accessible in one place. Click on the Sign up button and start looking after the health of your career.
ThinkGP
Duration
6 weeks
Accredited
-
ACRRM - Australian College of Rural and Remote Medicine
-
RACGP - Royal Australian College of General Practitioners